期刊文献+

康艾注射液在子宫颈癌术后同步放化疗中的应用及对患者血清IGF-2、SCC、IFN-γ水平的影响 被引量:5

Application of Kang'ai Injection in Concurrent Radiochemotherapy of Cervical Cancer Postoperation and Serum IGF-2,SCC and IFN-γ Levels
原文传递
导出
摘要 目的:分析康艾注射液用于子宫颈癌术后同步放化疗中的临床效果及对患者血清胰岛素样生长因子-2(IGF-2)、鳞状细胞癌抗原(SCC)、干扰素-γ(IFN-γ)水平的影响。方法:选择我院2014年8月~2016年8月收治的102例子宫颈癌患者,依据抽签法分为对照组与研究组,每组各51例。两组均行腹腔镜宫颈癌切除术,对照组于术后采用同步放化疗,研究组基于对照组加以康艾注射液治疗。比较两组的临床疗效,治疗前后血清IGF-2、SCC、IFN-γ水平,NK细胞、CD3^+、CD4^+、CD8^+、CD4^+/CD8^+以及不良反应的发生情况。结果:治疗后,研究组总有效率显著高于对照组(P<0.05)。治疗后,两组血清IGF-2、SCC、IFN-γ水平、CD8^+均较治疗前显著降低,且研究组以上指标显著低于对照组;两组NK细胞、CD3^+、CD4^+均较治疗前明显上升,且研究组以上指标显著高于对照组,差异均有统计学意义(P<0.05)。研究组不良反应的发生率明显低于对照组(P<0.05)。结论:康艾注射液用于子宫颈癌术后同步放化疗的临床效果确切,且能够显著降低患者血清IGF-2、SCC、IFN-γ水平并改善患者的免疫功能。 Objective:To analyze the clinical effects of Kang'ai injection on cervical cancer postoperative chemoradiation and the serum levels of insulin-like growth factor 2(IGF-2),squamous cell carcinoma antigen(SCC) and interferon-γ(IFN-γ).Methods:102 cases with cervical cancer who were treated in our hospital from August 2014 to August 2016 were selected and randomly divided into the control group and the research group with 51 cases in each group.The patients in the control group were treated with concurrent chemoradiation and chemotherapy,while the patients in the research group were treated with Kang'ai injection on the basis of control group.Then the clinical curative effect,serum levels of IGF-2,SCC,IFN-γ,NK cells,CD3+,CD4+,CD8+and CD4+/CD8+ and the incidence of adverse reactions were observed and compared between two groups before and after the treatment.Results:The total effective rate of research group was higher than that of the control group(P〈0.05).After treatment,the serum levels of IGF-2,SCC,IFN-γ and CD8+ in both groups were decreased,which were lower in the research group than those of the control group(P〈0.05).After treatment,the levels of NK cells,CD3+ and CD4+ in both groups were increased,which were higher in the research group than those of the control group(P〈0.05).The incidence of adverse reactions in the research group was lower than that of the control group(P〈0.05).Conclusion:Kang'ai injection could effectively reduce the serum levels of IGF-2,SCC and IFN-γ,and improve the immune functions of patients with cervical cancer postoperative chemoradiation.
作者 王晋 王月玲 谭宏伟 米阳 刘丹 WANG Jin;WANG Yue-ling;TAN Hong-wei;MI Yang;LIU Dan(Department of Obstetrics and Gynecology,northwest women and children's Hospital,Xi'an,Shaanxi,710054,China;Department of Obstetrics and Gynecology,the First Affiliated Hospital of Xi'an Jiao Tong University,Xi'an,Shaanxi,710061,China)
出处 《现代生物医学进展》 CAS 2018年第18期3510-3513,共4页 Progress in Modern Biomedicine
基金 陕西省自然科学基金项目(9K0569)
关键词 子宫颈癌 康艾注射液 同步放化疗 胰岛素样生长因子-2 鳞状细胞癌抗原 干扰素-γ Cervical cancer Kang'ai injection Concurrent chemoradiotherapy Insulin-like growth factor 2 Squamous cell carcinomaantigen Interferon-γ
  • 相关文献

参考文献2

二级参考文献9

  • 1郑敏,陈聪,赵雅萍,吴娟丽.探讨大鼠肝硬化动物模型的建立方法[J].肝胆外科杂志,2006,14(2):136-137. 被引量:15
  • 2Moreira R K. Hepatic stellate cells and liver fibrosis [ J ]. Arch Pathol Lab Med ,2007,131 ( 11 ) : 1728.
  • 3Kisseleva T, Brenner D A. Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis [ J ]. J Gastroentcrol Hepatol,2007, 22(S1) :73.
  • 4Reeves H L, Friedman S L. Activation of hepatic stellate cells-a key issue in liver fibrosis[J]. Front Biosei,2002,7:808.
  • 5Daniel F B, Leandra N Z R, Fernando S R, et al. Liver cirrhosis and hepatic stellate cells[ J ]. Acta Cirurgiea Brasileira, 2006,21 (1):54.
  • 6Liu H, Wei W, Sun W Y, et al. Protective effects of astragaloside IV on porcine-serum-induced hepatic fibrosis in rats and in vitro effects on hepatic stellate cells[ J]. J Ethnopharumcol, 2009,122 (3) : 502.
  • 7Sun W Y, Wei W, Wu L, et al. Effects and mechanisms of extract from Paeonia lactiflora and Astragalus membranaceus on liver fibrosis induced by carbon tetrachloride in rats[ J ]. J Ethnopharmacol, 2007,112(3) : 514.
  • 8高志星,尤龙,李蕾,张红梅.氧化苦参碱对肝纤维化大鼠保护机制的研究[J].中国医学创新,2009,6(26):20-22. 被引量:6
  • 9杨文卓,曾民德,陆伦根,茅益民,范竹萍,曹爱萍,宋育林,贾一韬.氧化苦参碱预防肝纤维化的实验研究[J].肝脏,2002,7(3):165-167. 被引量:12

共引文献27

同被引文献95

引证文献5

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部